Peter C C Fong

Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final totale...

Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final totale overleving re...

First-line talazoparib plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostat...

First-line talazoparib plus enzalutamide versus placebo plus enzalutamide in men with metastatic castration-resistant...

Talazoparib plus enzalutamide bij mCRPC: TALAPRO-2 veiligheid

Talazoparib plus enzalutamide bij eerstelijns mCRPC: TALAPRO-2 fase III